/RKDA
RKDA Stock - Arcadia Biosciences, Inc.
Basic Materials|Agricultural InputsNASDAQ
$3.69-0.81%
$0.03 (-0.81%) • Dec 19
74
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.37
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+62.6%upside
Target: $6.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for RKDA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$3.65 – $3.73
TARGET (TP)$6.00
STOP LOSS$3.39
RISK/REWARD1:7.7
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.48
52W High$6.71
52W Low$2.53
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $5.04M | $4.45M | $7.42M | $6.78M | $8.03M |
| Gross Profit | $2.08M | $2.28M | $1.32M | $-1,928,000 | $2.83M |
| Gross Margin | 41.3% | 51.2% | 17.8% | -28.4% | 35.3% |
| Operating Income | $-3,648,000 | $-6,102,000 | $-14,007,000 | $-35,526,000 | $-12,778,000 |
| Net Income | $-7,038,000 | $-13,981,000 | $-15,376,000 | $-14,660,000 | $-4,655,000 |
| Net Margin | -139.5% | -313.9% | -207.3% | -216.2% | -57.9% |
| EPS | $-5.16 | $-11.30 | $-26.05 | $-30.33 | $-24.20 |
Company Overview
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
RKDABeat Rate
61%
Last 18 quarters
Avg Surprise
+17.9%
EPS vs Estimate
Beats / Misses
11/7
Last 12 quarters
Latest EPS
$0.62
Q4 2025
EPS Surprise History
Q1 24
+7.5%
$-2.48vs$-2.68
Q2 24
+29.4%
$-1.78vs$-2.52
Q3 24
-49.7%
$0.78vs$1.55
Q4 24
-13.0%
$-0.87vs$-0.77
Q1 25
-178.7%
$-2.48vs$-0.89
Q2 25
+293.9%
$1.90vs$-0.98
Q3 25
+102.5%
$0.02vs$-0.79
Q4 25
+214.8%
$0.62vs$-0.54
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Mar 18, 2026 | — | — | — | — |
Q4 2025 | Nov 7, 2025 | $-0.54 | $0.62 | +214.8% | ✓ BEAT |
Q3 2025 | Aug 14, 2025 | $-0.79 | $0.02 | +102.5% | ✓ BEAT |
Q2 2025 | May 8, 2025 | $-0.98 | $1.90 | +293.9% | ✓ BEAT |
Q1 2025 | Mar 20, 2025 | $-0.89 | $-2.48 | -178.7% | ✗ MISS |
Q4 2024 | Nov 12, 2024 | $-0.77 | $-0.87 | -13.0% | ✗ MISS |
Q3 2024 | Aug 13, 2024 | $1.55 | $0.78 | -49.7% | ✗ MISS |
Q2 2024 | May 9, 2024 | $-2.52 | $-1.78 | +29.4% | ✓ BEAT |
Q1 2024 | Mar 28, 2024 | $-2.68 | $-2.48 | +7.5% | ✓ BEAT |
Q4 2023 | Nov 9, 2023 | $-2.67 | $-1.83 | +31.5% | ✓ BEAT |
Q3 2023 | Aug 10, 2023 | $-4.92 | $-2.64 | +46.3% | ✓ BEAT |
Q2 2023 | May 15, 2023 | $-6.35 | $-3.83 | +39.7% | ✓ BEAT |
Q1 2023 | Mar 30, 2023 | $6.80 | $-6.31 | -192.8% | ✗ MISS |
Q4 2022 | Nov 10, 2022 | $-7.60 | $-4.80 | +36.8% | ✓ BEAT |
Q3 2022 | Aug 11, 2022 | $-12.40 | $-6.80 | +45.2% | ✓ BEAT |
Q2 2022 | May 12, 2022 | $-12.40 | $-8.40 | +32.3% | ✓ BEAT |
Q1 2022 | Mar 30, 2022 | $-11.20 | $-16.80 | -50.0% | ✗ MISS |
Q4 2021 | Nov 15, 2021 | $-9.20 | $-14.80 | -60.9% | ✗ MISS |
Q3 2021 | Aug 16, 2021 | $-9.20 | $-10.40 | -13.0% | ✗ MISS |
Latest News
Arcadia Biosciences Q3 EPS $0.63, Sales $1.302M Miss $1.900M Estimate
📉 NegativeBenzinga•Nov 7, 2025, 09:07 PM
Arcadia Biosciences Shares Halted On Circuit Breaker To The Downside, Stock Now Up 73.37%
➖ NeutralBenzinga•Oct 8, 2025, 06:15 PM
Arcadia Biosciences CFO Mark Kawakami Resigns Effective September 12, 2025; Thomas J. Schaefer Appointed Interim CFO
➖ NeutralBenzinga•Aug 29, 2025, 09:19 PM
Arcadia Biosciences Sales Up 11 Percent
📈 PositiveThe Motley Fool•Aug 14, 2025, 09:40 PM
Frequently Asked Questions about RKDA
What is RKDA's current stock price?
Arcadia Biosciences, Inc. (RKDA) is currently trading at $3.69 per share. The stock has moved -0.81% today.
What is the analyst price target for RKDA?
The average analyst price target for RKDA is $6.00, based on 1 analyst.
What sector is Arcadia Biosciences, Inc. in?
Arcadia Biosciences, Inc. operates in the Basic Materials sector, specifically within the Agricultural Inputs industry. The company is traded on the NASDAQ exchange.
What is RKDA's market cap?
Arcadia Biosciences, Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does RKDA pay dividends?
No, Arcadia Biosciences, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Basic Materials SectorCAPS
Capstone Holding Corp.
$0.76
Mkt Cap: $0.0B
CNEY
CN ENERGY GROUP INC.
$0.62
Mkt Cap: $0.0B
ENFY
Enlightify Inc.
$0.09
Mkt Cap: $0.0B
FMSTW
Foremost Lithium Resource & Technology Ltd.
$1.07
Mkt Cap: $0.0B
GURE
Gulf Resources, Inc.
$4.29
Mkt Cap: $0.0B
INHD
Inno Holdings Inc. Common Stock
$0.07
Mkt Cap: $0.0B
ITP
IT Tech Packaging, Inc.
$0.24
Mkt Cap: $0.0B
NITO
N2OFF, Inc.
$2.57
Mkt Cap: $0.0B
QTZM
Quantumzyme Corp.
$2.39
Mkt Cap: $0.1B
RETO
ReTo Eco-Solutions, Inc.
$2.12
Mkt Cap: $0.0B
Explore stocks similar to RKDA for comparison